U.S. Army Medical Research and Development Command: Fever trials

The registry lists 10 Fever studies with U.S. Army Medical Research and Development Command as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase 2 Safety and Immunogenicity Study of Rift Valley Fever VaccineRecruitingNCT03609398Phase 2
• Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic FeverCompletedNCT02116205Phase 2Results posted
• Safety Evaluation of a Q-fever Vaccine, NDBR 105CompletedNCT00584454Phase 2Results posted
• Safety and Immunogenicity Study of Rift Valley Fever VaccineCompletedNCT00584194Phase 2Results posted
• A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2Results posted
• Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever VaccineCompletedNCT00415051Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA VaccinesCompletedNCT01502345Phase 1
• Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment FacilitiesWithdrawnNCT00992693Phase 2
• Safety and Immunogenicity Study of Rift Valley Fever Vaccine, InactivatedCompletedNCT00869713Phase 2
• Ribavirin for Hemorrhagic Fever With Renal Syndrome in GermanyWithdrawnNCT00868946Phase 2